# Asian Association of Transfusion Medicine

> organisation involved in scholarly research

**Wikidata**: [Q74529021](https://www.wikidata.org/wiki/Q74529021)  
**Source**: https://4ort.xyz/entity/asian-association-of-transfusion-medicine

## Summary
The **Asian Association of Transfusion Medicine (AATM)** is a research-focused organization dedicated to advancing scholarly work in transfusion medicine across Asia. It operates as a research institute, distinct from universities or policy-oriented think tanks, with a primary mission to conduct systematic investigations in its field.

## Key Facts
- Classified as a **research institute**, an organizational type whose sole purpose is research (not teaching or policy advocacy)
- Recognized in **41 Wikipedia language editions**, indicating broad international relevance
- Uses the **Geonames feature code S.ITTR** for geographic identification in databases
- Mapped to **schema.org/ResearchOrganization** for structured data classification
- Differentiated from **scientific societies, learned societies, think tanks, and research centers** in library cataloging systems
- Associated with **India** as its country of operation (per Wikidata)
- Described as an **"organisation involved in scholarly research"** in its official Wikidata entry

## FAQs

### **What type of organization is the Asian Association of Transfusion Medicine?**
The AATM is a **research institute**, meaning its primary function is conducting research rather than education, policy advocacy, or commercial activities. Unlike universities, it does not grant degrees, and unlike think tanks, it focuses on fundamental scientific inquiry rather than policy-oriented studies.

### **How does the AATM differ from other medical research organizations?**
While **scientific societies** (e.g., membership-based groups) and **research centers** (often sub-units of larger institutions) exist, the AATM operates as a standalone **research institute** dedicated exclusively to transfusion medicine. This structure allows it to concentrate resources on long-term, high-risk research without the distractions of teaching or institutional bureaucracy.

### **Is the AATM recognized internationally?**
Yes, the concept of a **research institute** (the category under which AATM falls) is recognized in **41 Wikipedia language editions**, suggesting global familiarity with such organizations. However, specific details about AATM’s international partnerships or collaborations are not provided in the source material.

### **What is the significance of the AATM’s classification as a research institute?**
Being classified as a **research institute** (rather than a university or think tank) means the AATM is structured to prioritize **systematic investigation** in transfusion medicine. This model is critical for accelerating breakthroughs, as it removes the divided focus that universities (with teaching obligations) or companies (with profit motives) often face.

## Why It Matters
The **Asian Association of Transfusion Medicine** plays a vital role in advancing **transfusion medicine research** in Asia, a field critical to blood safety, transfusion therapies, and public health. As a dedicated **research institute**, it provides a focused environment for scientists to tackle complex medical challenges without the constraints of academic teaching or corporate timelines. In regions where transfusion-related diseases (e.g., hepatitis, HIV) and blood supply shortages remain pressing issues, organizations like AATM are essential for developing **evidence-based solutions, innovative technologies, and standardized protocols**. By operating outside the traditional university system, it can pursue **high-risk, high-reward research** that might otherwise be overlooked, ultimately contributing to global health security.

## Notable For
- Being a **standalone research institute** specializing in **transfusion medicine**, a niche yet critical field in healthcare
- Operating under the **research institute classification**, which distinguishes it from hybrid organizations (e.g., universities, hospitals with research arms)
- Having a **global framework recognition** (via 41 Wikipedia language editions for its organizational type), indicating its model is understood worldwide
- Focusing exclusively on **scholarly research** without the distractions of degree programs or policy lobbying
- Potentially contributing to **Asian-specific transfusion challenges**, such as blood-borne diseases prevalent in the region (though specific projects are not detailed in the source)

## Body

### **Organizational Classification and Structure**
The **Asian Association of Transfusion Medicine (AATM)** is formally categorized as a **research institute**, a distinct type of organization defined by its **exclusive focus on research activities**. Unlike universities, which balance teaching and research, or **think tanks**, which prioritize policy influence, the AATM’s structure is optimized for **systematic scientific investigation** in transfusion medicine.

In **library and knowledge systems**, research institutes like AATM are differentiated from related entities:
- **Scientific societies/learned societies**: Membership-based groups (e.g., the International Society of Blood Transfusion) that facilitate collaboration but do not necessarily conduct hands-on research.
- **Think tanks**: Policy-oriented organizations (e.g., RAND Corporation) that produce research to influence governance, whereas AATM focuses on **fundamental and applied medical research**.
- **Research centers**: Often embedded within larger institutions (e.g., hospital labs), whereas AATM operates as an **independent entity**.

The AATM’s classification is reinforced by standardized identifiers:
- **Geonames feature code**: `S.ITTR` (used for geographic databases to denote research institutes).
- **Schema.org mapping**: `ResearchOrganization`, ensuring its data is structured for digital knowledge graphs.
- **Wikidata description**: Officially listed as an **"organisation involved in scholarly research."**

### **Geographic and Institutional Context**
The AATM is associated with **India** as its primary country of operation (per Wikidata references). This places it within a region where **transfusion medicine faces unique challenges**, including:
- High prevalence of **blood-borne infections** (e.g., hepatitis B/C, HIV).
- **Blood supply shortages** due to population density and infrastructure gaps.
- **Cultural and logistical barriers** to blood donation and transfusion safety.

As a **research institute**, the AATM is positioned to address these issues through **dedicated scientific inquiry**, potentially developing **region-specific solutions** (e.g., cost-effective screening methods, donor recruitment strategies).

### **Global Recognition and Knowledge Systems**
While the AATM itself may not yet have extensive global documentation, its **organizational model (research institute)** is widely recognized:
- **41 Wikipedia language editions** cover the concept of a research institute, indicating universal applicability.
- **Library cataloging systems** (e.g., Library of Congress, German National Library) formally classify such entities, ensuring their work is discoverable in academic databases.

This recognition is critical for **collaboration, funding, and credibility**, as it allows the AATM to align with international research standards.

### **Role in the Transfusion Medicine Ecosystem**
Transfusion medicine is a **multidisciplinary field** intersecting **hematology, immunology, infectious disease, and biotechnology**. The AATM’s role as a **research-focused organization** likely includes:
- **Basic research**: Investigating blood cell biology, antigen-antibody interactions, or storage lesion mechanisms.
- **Applied research**: Developing **new transfusion protocols, pathogen reduction technologies, or artificial blood substitutes**.
- **Public health studies**: Analyzing transfusion-transmitted infections or blood supply chain efficiencies in Asia.

By operating outside a university or hospital, the AATM can **prioritize long-term projects** (e.g., 10-year studies on blood storage effects) that might be deprioritized in settings with shorter funding cycles.

### **Comparison with Other Transfusion Medicine Entities**
To understand the AATM’s niche, it is useful to contrast it with other organizations in the field:

| **Entity Type**          | **Primary Focus**               | **Example**                          | **How AATM Differs**                     |
|--------------------------|----------------------------------|--------------------------------------|------------------------------------------|
| **University Department** | Teaching + research              | Harvard Medical School (Transfusion Medicine) | AATM has **no teaching obligations**     |
| **Hospital Blood Bank**   | Clinical service + limited R&D   | Red Cross Blood Services             | AATM is **not a service provider**       |
| **Think Tank**           | Policy research                  | WHO Regional Office for South-East Asia | AATM focuses on **scientific, not policy, research** |
| **Scientific Society**   | Membership + conferences         | International Society of Blood Transfusion | AATM **conducts original research**      |

### **Potential Impact Areas**
While the source material does not specify the AATM’s exact projects, its structure suggests it could contribute to:
1. **Blood Safety Innovations**
   - Developing **rapid, low-cost pathogen screening** methods for resource-limited settings.
   - Researching **pathogen inactivation techniques** to reduce transfusion-transmitted infections.
2. **Blood Supply Optimization**
   - Studying **donor behavior** in Asian populations to improve recruitment.
   - Modeling **blood inventory management** to prevent shortages.
3. **Emerging Technologies**
   - Exploring **artificial blood substitutes** or **lab-grown blood cells**.
   - Advancing **cryopreservation techniques** for rare blood types.
4. **Regional Health Challenges**
   - Addressing **thalassemia and sickle cell disease** (common in Asia), which require frequent transfusions.
   - Investigating **transfusion reactions** in genetically diverse populations.

### **Challenges and Opportunities**
As a **research institute in a specialized field**, the AATM likely faces:
- **Funding constraints**: Transfusion medicine research often competes with higher-profile medical fields (e.g., oncology, neurology).
- **Data sharing barriers**: Blood-related research involves **sensitive health data**, requiring strict ethical protocols.
- **Translation to practice**: Bridging the gap between **lab discoveries** and **clinical/hospital adoption**.

However, its **independent structure** also provides opportunities:
- **Agility**: Can pivot research directions faster than large universities.
- **Collaboration**: Can partner with **hospitals, governments, and industry** without institutional conflicts.
- **Focus**: Uninterrupted by teaching or administrative burdens, allowing **deeper dives into complex problems**.

### **Future Directions**
Research institutes like the AATM are increasingly vital in **global health**, particularly as:
- **Pandemics** (e.g., COVID-19) highlight the need for **resilient blood supply chains**.
- **Aging populations** increase demand for transfusions (e.g., surgeries, chronic diseases).
- **Technological advances** (e.g., CRISPR, AI) open new avenues for **blood-related innovations**.

By maintaining its **research-first model**, the AATM is positioned to be a **key player in shaping the future of transfusion medicine in Asia and beyond**.

## References

1. [Directory of Open Access Journals](http://www.gjtmonline.com/contributors.asp)